Global DTaP Vaccine Market Growth 2022-2028
- LP 4835214
- 75 Pages
- February 2022
- Pharmaceuticals
The United States DTaP Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global DTaP Vaccine market, reaching US$ million by the year 2028. As for the Europe DTaP Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main DTaP Vaccine players cover GlaxoSmithKline, Sanofi Pasteur, Ltd., Merck, and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of DTaP Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Inactivated Vaccine
Live Attenuated Vaccine
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Government Institution
Private Sector
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GlaxoSmithKline
Sanofi Pasteur, Ltd.
Merck
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global DTaP Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for DTaP Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for DTaP Vaccine by Country/Region, 2017, 2022 & 2028
2.2 DTaP Vaccine Segment by Type
2.2.1 Inactivated Vaccine
2.2.2 Live Attenuated Vaccine
2.3 DTaP Vaccine Sales by Type
2.3.1 Global DTaP Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global DTaP Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global DTaP Vaccine Sale Price by Type (2017-2022)
2.4 DTaP Vaccine Segment by Application
2.4.1 Government Institution
2.4.2 Private Sector
2.4.3 Other
2.5 DTaP Vaccine Sales by Application
2.5.1 Global DTaP Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global DTaP Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global DTaP Vaccine Sale Price by Application (2017-2022)
3 Global DTaP Vaccine by Company
3.1 Global DTaP Vaccine Breakdown Data by Company
3.1.1 Global DTaP Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global DTaP Vaccine Sales Market Share by Company (2020-2022)
3.2 Global DTaP Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global DTaP Vaccine Revenue by Company (2020-2022)
3.2.2 Global DTaP Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global DTaP Vaccine Sale Price by Company
3.4 Key Manufacturers DTaP Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers DTaP Vaccine Product Location Distribution
3.4.2 Players DTaP Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for DTaP Vaccine by Geographic Region
4.1 World Historic DTaP Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global DTaP Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global DTaP Vaccine Annual Revenue by Geographic Region
4.2 World Historic DTaP Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global DTaP Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global DTaP Vaccine Annual Revenue by Country/Region
4.3 Americas DTaP Vaccine Sales Growth
4.4 APAC DTaP Vaccine Sales Growth
4.5 Europe DTaP Vaccine Sales Growth
4.6 Middle East & Africa DTaP Vaccine Sales Growth
5 Americas
5.1 Americas DTaP Vaccine Sales by Country
5.1.1 Americas DTaP Vaccine Sales by Country (2017-2022)
5.1.2 Americas DTaP Vaccine Revenue by Country (2017-2022)
5.2 Americas DTaP Vaccine Sales by Type
5.3 Americas DTaP Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC DTaP Vaccine Sales by Region
6.1.1 APAC DTaP Vaccine Sales by Region (2017-2022)
6.1.2 APAC DTaP Vaccine Revenue by Region (2017-2022)
6.2 APAC DTaP Vaccine Sales by Type
6.3 APAC DTaP Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe DTaP Vaccine by Country
7.1.1 Europe DTaP Vaccine Sales by Country (2017-2022)
7.1.2 Europe DTaP Vaccine Revenue by Country (2017-2022)
7.2 Europe DTaP Vaccine Sales by Type
7.3 Europe DTaP Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa DTaP Vaccine by Country
8.1.1 Middle East & Africa DTaP Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa DTaP Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa DTaP Vaccine Sales by Type
8.3 Middle East & Africa DTaP Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of DTaP Vaccine
10.3 Manufacturing Process Analysis of DTaP Vaccine
10.4 Industry Chain Structure of DTaP Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 DTaP Vaccine Distributors
11.3 DTaP Vaccine Customer
12 World Forecast Review for DTaP Vaccine by Geographic Region
12.1 Global DTaP Vaccine Market Size Forecast by Region
12.1.1 Global DTaP Vaccine Forecast by Region (2023-2028)
12.1.2 Global DTaP Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global DTaP Vaccine Forecast by Type
12.7 Global DTaP Vaccine Forecast by Application
13 Key Players Analysis
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline DTaP Vaccine Product Offered
13.1.3 GlaxoSmithKline DTaP Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Sanofi Pasteur, Ltd.
13.2.1 Sanofi Pasteur, Ltd. Company Information
13.2.2 Sanofi Pasteur, Ltd. DTaP Vaccine Product Offered
13.2.3 Sanofi Pasteur, Ltd. DTaP Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sanofi Pasteur, Ltd. Main Business Overview
13.2.5 Sanofi Pasteur, Ltd. Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck DTaP Vaccine Product Offered
13.3.3 Merck DTaP Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
14 Research Findings and Conclusion
Table 1. DTaP Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. DTaP Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Inactivated Vaccine
Table 4. Major Players of Live Attenuated Vaccine
Table 5. Global DTaP Vaccine Sales by Type (2017-2022) & (K Doses)
Table 6. Global DTaP Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global DTaP Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global DTaP Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global DTaP Vaccine Sale Price by Type (2017-2022) & (US$/Dose)
Table 10. Global DTaP Vaccine Sales by Application (2017-2022) & (K Doses)
Table 11. Global DTaP Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global DTaP Vaccine Revenue by Application (2017-2022)
Table 13. Global DTaP Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global DTaP Vaccine Sale Price by Application (2017-2022) & (US$/Dose)
Table 15. Global DTaP Vaccine Sales by Company (2020-2022) & (K Doses)
Table 16. Global DTaP Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global DTaP Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global DTaP Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global DTaP Vaccine Sale Price by Company (2020-2022) & (US$/Dose)
Table 20. Key Manufacturers DTaP Vaccine Producing Area Distribution and Sales Area
Table 21. Players DTaP Vaccine Products Offered
Table 22. DTaP Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global DTaP Vaccine Sales by Geographic Region (2017-2022) & (K Doses)
Table 26. Global DTaP Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global DTaP Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global DTaP Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global DTaP Vaccine Sales by Country/Region (2017-2022) & (K Doses)
Table 30. Global DTaP Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global DTaP Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global DTaP Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas DTaP Vaccine Sales by Country (2017-2022) & (K Doses)
Table 34. Americas DTaP Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas DTaP Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas DTaP Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas DTaP Vaccine Sales by Type (2017-2022) & (K Doses)
Table 38. Americas DTaP Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas DTaP Vaccine Sales by Application (2017-2022) & (K Doses)
Table 40. Americas DTaP Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC DTaP Vaccine Sales by Region (2017-2022) & (K Doses)
Table 42. APAC DTaP Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC DTaP Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC DTaP Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC DTaP Vaccine Sales by Type (2017-2022) & (K Doses)
Table 46. APAC DTaP Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC DTaP Vaccine Sales by Application (2017-2022) & (K Doses)
Table 48. APAC DTaP Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe DTaP Vaccine Sales by Country (2017-2022) & (K Doses)
Table 50. Europe DTaP Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe DTaP Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe DTaP Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe DTaP Vaccine Sales by Type (2017-2022) & (K Doses)
Table 54. Europe DTaP Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe DTaP Vaccine Sales by Application (2017-2022) & (K Doses)
Table 56. Europe DTaP Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa DTaP Vaccine Sales by Country (2017-2022) & (K Doses)
Table 58. Middle East & Africa DTaP Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa DTaP Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa DTaP Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa DTaP Vaccine Sales by Type (2017-2022) & (K Doses)
Table 62. Middle East & Africa DTaP Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa DTaP Vaccine Sales by Application (2017-2022) & (K Doses)
Table 64. Middle East & Africa DTaP Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of DTaP Vaccine
Table 66. Key Market Challenges & Risks of DTaP Vaccine
Table 67. Key Industry Trends of DTaP Vaccine
Table 68. DTaP Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. DTaP Vaccine Distributors List
Table 71. DTaP Vaccine Customer List
Table 72. Global DTaP Vaccine Sales Forecast by Region (2023-2028) & (K Doses)
Table 73. Global DTaP Vaccine Sales Market Forecast by Region
Table 74. Global DTaP Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global DTaP Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas DTaP Vaccine Sales Forecast by Country (2023-2028) & (K Doses)
Table 77. Americas DTaP Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC DTaP Vaccine Sales Forecast by Region (2023-2028) & (K Doses)
Table 79. APAC DTaP Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe DTaP Vaccine Sales Forecast by Country (2023-2028) & (K Doses)
Table 81. Europe DTaP Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa DTaP Vaccine Sales Forecast by Country (2023-2028) & (K Doses)
Table 83. Middle East & Africa DTaP Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global DTaP Vaccine Sales Forecast by Type (2023-2028) & (K Doses)
Table 85. Global DTaP Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global DTaP Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global DTaP Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global DTaP Vaccine Sales Forecast by Application (2023-2028) & (K Doses)
Table 89. Global DTaP Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global DTaP Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global DTaP Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. GlaxoSmithKline Basic Information, DTaP Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. GlaxoSmithKline DTaP Vaccine Product Offered
Table 94. GlaxoSmithKline DTaP Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 95. GlaxoSmithKline Main Business
Table 96. GlaxoSmithKline Latest Developments
Table 97. Sanofi Pasteur, Ltd. Basic Information, DTaP Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Sanofi Pasteur, Ltd. DTaP Vaccine Product Offered
Table 99. Sanofi Pasteur, Ltd. DTaP Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 100. Sanofi Pasteur, Ltd. Main Business
Table 101. Sanofi Pasteur, Ltd. Latest Developments
Table 102. Merck Basic Information, DTaP Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Merck DTaP Vaccine Product Offered
Table 104. Merck DTaP Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 105. Merck Main Business
Table 106. Merck Latest Developments
List of Figures
Figure 1. Picture of DTaP Vaccine
Figure 2. DTaP Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global DTaP Vaccine Sales Growth Rate 2017-2028 (K Doses)
Figure 7. Global DTaP Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. DTaP Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Inactivated Vaccine
Figure 10. Product Picture of Live Attenuated Vaccine
Figure 11. Global DTaP Vaccine Sales Market Share by Type in 2021
Figure 12. Global DTaP Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. DTaP Vaccine Consumed in Government Institution
Figure 14. Global DTaP Vaccine Market: Government Institution (2017-2022) & (K Doses)
Figure 15. DTaP Vaccine Consumed in Private Sector
Figure 16. Global DTaP Vaccine Market: Private Sector (2017-2022) & (K Doses)
Figure 17. DTaP Vaccine Consumed in Other
Figure 18. Global DTaP Vaccine Market: Other (2017-2022) & (K Doses)
Figure 19. Global DTaP Vaccine Sales Market Share by Application (2017-2022)
Figure 20. Global DTaP Vaccine Revenue Market Share by Application in 2021
Figure 21. DTaP Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 22. Global DTaP Vaccine Revenue Market Share by Company in 2021
Figure 23. Global DTaP Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global DTaP Vaccine Revenue Market Share by Geographic Region in 2021
Figure 25. Global DTaP Vaccine Sales Market Share by Region (2017-2022)
Figure 26. Global DTaP Vaccine Revenue Market Share by Country/Region in 2021
Figure 27. Americas DTaP Vaccine Sales 2017-2022 (K Doses)
Figure 28. Americas DTaP Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. APAC DTaP Vaccine Sales 2017-2022 (K Doses)
Figure 30. APAC DTaP Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Europe DTaP Vaccine Sales 2017-2022 (K Doses)
Figure 32. Europe DTaP Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa DTaP Vaccine Sales 2017-2022 (K Doses)
Figure 34. Middle East & Africa DTaP Vaccine Revenue 2017-2022 ($ Millions)
Figure 35. Americas DTaP Vaccine Sales Market Share by Country in 2021
Figure 36. Americas DTaP Vaccine Revenue Market Share by Country in 2021
Figure 37. United States DTaP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada DTaP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico DTaP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil DTaP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC DTaP Vaccine Sales Market Share by Region in 2021
Figure 42. APAC DTaP Vaccine Revenue Market Share by Regions in 2021
Figure 43. China DTaP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan DTaP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea DTaP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia DTaP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. India DTaP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia DTaP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe DTaP Vaccine Sales Market Share by Country in 2021
Figure 50. Europe DTaP Vaccine Revenue Market Share by Country in 2021
Figure 51. Germany DTaP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. France DTaP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK DTaP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy DTaP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia DTaP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa DTaP Vaccine Sales Market Share by Country in 2021
Figure 57. Middle East & Africa DTaP Vaccine Revenue Market Share by Country in 2021
Figure 58. Egypt DTaP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa DTaP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel DTaP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey DTaP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country DTaP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of DTaP Vaccine in 2021
Figure 64. Manufacturing Process Analysis of DTaP Vaccine
Figure 65. Industry Chain Structure of DTaP Vaccine
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
